These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3312417)

  • 21. An early component of delayed-type hypersensitivity mediated by T cells and mast cells.
    van Loveren H; Meade R; Askenase PW
    J Exp Med; 1983 May; 157(5):1604-17. PubMed ID: 6602201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MD41, a novel T helper 0 clone, mediates mast-cell dependent delayed-type hypersensitivity in mice.
    Torii I; Morikawa S; Harada T
    Immunology; 2002 Dec; 107(4):426-34. PubMed ID: 12460187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cells that mediate NK like cytotoxicity are present in the human delayed type hypersensitivity response.
    Tartof D; Yung CW; Curran JJ; Livingston C; Thalji Z
    Clin Exp Immunol; 1984 Nov; 58(2):462-9. PubMed ID: 6499283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In situ suppression of delayed-type hypersensitivity: another mechanism for sustaining the immune privilege of the anterior chamber.
    Benson JL; Niederkorn JY
    Immunology; 1991 Sep; 74(1):153-9. PubMed ID: 1937568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of delayed-type hypersensitivity to sheep red blood cells in mice by granulocyte colony-stimulating factor administration at the elicitation phase.
    Terashita M; Kudo C; Yamashita T; Gresser I; Sendo F
    J Immunol; 1996 Jun; 156(12):4638-43. PubMed ID: 8648107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of delayed-type hypersensitivity and interferon-gamma to Candida albicans and anti-hen-egg white lysozyme antibody as phenotypic markers of enhanced bovine immune response.
    Heriazon A; Yager JA; Sears W; Mallard BA
    Vet Immunol Immunopathol; 2009 May; 129(1-2):93-100. PubMed ID: 19155071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration.
    Charlesworth EN; Hood AF; Soter NA; Kagey-Sobotka A; Norman PS; Lichtenstein LM
    J Clin Invest; 1989 May; 83(5):1519-26. PubMed ID: 2468688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous delayed-type hypersensitivity (DTH) in a multi-formulation comparator trial of the anti-falciparum malaria vaccine candidate RTS,S in rhesus macaques.
    Stewart VA; Walsh DS; McGrath SM; Kester KE; Cummings JF; Voss G; Delchambre M; Garçon N; Cohen JD; Heppner DG
    Vaccine; 2006 Oct; 24(42-43):6493-502. PubMed ID: 16911849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of IFN-gamma in delayed-type hypersensitivity mediated by Th1 clones.
    Fong TA; Mosmann TR
    J Immunol; 1989 Nov; 143(9):2887-93. PubMed ID: 2530282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preferential induction of memory T cells for delayed-type hypersensitivity with reduced and alkylated human serum albumin in mice.
    Kojima A; Tamura SI; Egashira Y
    Immunology; 1979 Dec; 38(4):717-25. PubMed ID: 93084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed-type hypersensitivity skin testing in human immunodeficiency virus-infected pediatric patients.
    Raszka WV; Moriarty RA; Ottolini MG; Waecker NJ; Ascher DP; Cieslak TJ; Fischer GW; Robb ML
    J Pediatr; 1996 Aug; 129(2):245-50. PubMed ID: 8765622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell-mediated immunity in healthy and uremic adults assessed by in vivo and in vitro techniques. Validation of delayed hypersensitivity skin testing.
    López M; Jerez J; González M; Arias M
    Allergol Immunopathol (Madr); 1989; 17(1):21-8. PubMed ID: 2750637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells.
    Ptak W; Herzog WR; Askenase PW
    J Immunol; 1991 Jan; 146(2):469-75. PubMed ID: 1987274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local passive transfer of delayed-type hypersensitivity in the mouse.
    Scovern H; Kantor FS
    J Immunol; 1982 Jul; 129(1):25-9. PubMed ID: 6177751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic properties and cytokine production of skin-infiltrating cells obtained from guinea pig delayed-type hypersensitivity reaction sites.
    Higashi N; Yoshizuka N; Kobayashi Y
    Cell Immunol; 1995 Aug; 164(1):28-35. PubMed ID: 7634350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monocyte response receptors in BCG driven delayed type hypersensitivity to tuberculin.
    Strapagiel D; Kasztalska K; Druszczyńska M; Kowalewicz-Kulbat M; Vrba A; Matusiak A; Chmiela M; Rudnicka W
    Folia Histochem Cytobiol; 2008; 46(3):353-9. PubMed ID: 19056540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skin reactivity and local cell recruitment in human atopic and nonatopic subjects by CCL2/MCP-1 and CCL3/MIP-1alpha.
    Gaga M; Ong YE; Benyahia F; Aizen M; Barkans J; Kay AB
    Allergy; 2008 Jun; 63(6):703-11. PubMed ID: 18070228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed-type hypersensitivity is mediated by a sequence of two different T cell activities.
    Van Loveren H; Askenase PW
    J Immunol; 1984 Nov; 133(5):2397-401. PubMed ID: 6332849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytology of tuberculin reaction.
    Müftüoğlu AU; Akman N; Başar I
    Acta Haematol; 1971; 46(2):121-8. PubMed ID: 5001571
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.